The facts on agricultural biotechnology are clear and compelling. We believe agricultural biotechnology products should be provided a timely, transparent and scientific review by the European Union, and that is why Canada, Argentina and the United States brought the case in the first place.
Quotes about biotechnology (16 Quotes)
Biotechnology is not just about farming. It's about business it's about our future, ... It doesn't affect just farmers it affects everyone.
We are excited to have Rachel as a key member of our senior analyst team. Rachel's consistency and commitment to excellence over the past five years have put her in a leadership position in our health care team and we look forward to her continued expansion of our biotechnology research platform.
The PPI numbers look pretty good. I think the important thing to look at is when this thing turns around, and I don't know that we yet have a clear picture that we definitely are in a slowdown mode, although there are some signs that we have slowed down, which sectors are likely to do well. And I think the important thing, if you look past the last two weeks, is that there is really a resurgence of the leadership of technology and biotechnology.
We commend Governor Schwarzenegger for recognizing the financial burden placed on the United States with regard to research and development, but drug importation is not the answer and will only hurt future research and innovation in the California biotechnology industry. We strongly encourage the governor to re-think his stance toward drug importation and to realize the economic damage it will cause our state, which now leads the world's life science industry.
We must support the industry that drives our state's economy. That means being very attentive to the needs of our farmers and ranchers. It means aggressively exploring opportunities in the areas of biotechnology, value-added agriculture, and foreign markets.
Rushing willy-nilly into the future without giving deep thought to the influences of biotechnology in the way we treat each other, and the impact it makes on social behavior, would be foolish indeed.
If you're a day trader and you can stomach market volatility on a day-to-day basis, ... and want to play that momentum, stick with technology and biotechnology. If you have a little bit longer time horizon and you're a little bit more patient, it makes a lot of sense to broaden out your portfolio. Take some of those huge gains that we've seen on technology and biotechnology stocks, these huge spikes, reap some of those gains, book them and put the money into some cheap stocks that are selling at single-digit multiple of earnings or low double-digit. There are a lot of cheap inexpensive stocks out there.
My sense is that we're ready for another industrial revolution in this country. The great minds and innovators of Silicon Valley would come through China and say, The pipeline is full of ideas - there's personalized medicine, biotechnology, new forms to power ourselves, clean energy, etc., etc.
The jewels are the vaccines business and blood testing. There's nothing about Chiron that makes you say 'wow, we need to buy this for the pipeline.' The portfolio is rather lackluster compared to other biotechnology companies.
Almost everybody is enthusiastic about the promise of biotechnology to cure disease and to relieve suffering.
The way we're really going to grow the economy is to invest in people, to invest in innovation, to have the federal government put money in the kind of research that will create the new high-technology, biotechnology industries that will create the millions of new jobs.
We agree that technology is probably the greatest area of growth both in biotechnology and information technology, but I think people need to balance that to dampen the volatility, and one of the areas to look at is in the natural resources area.
I really do believe it is feasible to slow down the aging process, ... We call that a bridge to a bridge to a bridge -- to the full flowering of the biotechnology revolution.
The company considered several attractive sites in other countries, but chose Ireland due to its thriving biotechnology community, infrastructure to support biologics manufacturing and attractive business climate. Our new facilities in Cork will enhance our ability to deliver on Amgen's robust pipeline.
I think the new biotechnology academy we're trying to implement will help them see the benefit of education.